Market Tracker

02/12 5:16pm ET

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

1.71
Delayed Data
As of Feb 12
 +0.05 / +3.01%
Today’s Change
1.63
Today|||52-Week Range
16.83
-83.43%
Year-to-Date

Today’s Trading

Previous close1.66
Today’s open1.71
Day’s range1.63 - 1.74
Volume1,832,885
Average volume (3 months)1,015,302
Market cap$125.4M
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-23.64%
Earnings growth (this year)+10.88%
Earnings growth (next 5 years)+19.86%
Revenue growth (last year)-21.48%
P/E ratioNM
Price/Sales59.67
Price/Book1.63

Competitors

 Today’s
change
Today’s
% change
BPTHBio Path Holdings In...+0.02+1.48%
AKTXAkari Therapeutics P...-1.14-9.50%
KMDAKamada Ltd+0.06+1.83%
ASTAsterias Biotherapeu...+0.08+2.40%
Data as of 4:01pm ET, 02/12/2016

Financials

Next reporting dateFebruary 23, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$13.6M
Annual profit (last year)-$45.2M
Net profit margin-332.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts